Moreover, PMNs expressing the dual endothelin1/signal peptide receptor in combination with CD11b and CD66b (DEspR+CD11b+/CD66b+) are associated with severity of hypoxemia and multi-organ failure in ARDS and might provide an actionable therapeutic target in ARDS [44]. This evidence concerns the gene ITGAM and acute respiratory distress syndrome.